Barclays’s Acorda Therapeutics, Inc. ACOR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q3
Sell
-100
Closed -$9K 3997
2020
Q2
$9K Sell
100
-222
-69% -$20K ﹤0.01% 3663
2020
Q1
$36K Sell
322
-262
-45% -$29.3K ﹤0.01% 3220
2019
Q4
$144K Buy
584
+149
+34% +$36.7K ﹤0.01% 3323
2019
Q3
$149K Sell
435
-124
-22% -$42.5K ﹤0.01% 3189
2019
Q2
$513K Buy
559
+251
+81% +$230K ﹤0.01% 2702
2019
Q1
$491K Sell
308
-112
-27% -$179K ﹤0.01% 2631
2018
Q4
$786K Sell
420
-382
-48% -$715K ﹤0.01% 1981
2018
Q3
$1.89M Buy
802
+469
+141% +$1.11M ﹤0.01% 1824
2018
Q2
$1.15M Buy
333
+184
+123% +$633K ﹤0.01% 1772
2018
Q1
$425K Buy
149
+78
+110% +$222K ﹤0.01% 2398
2017
Q4
$183K Buy
71
+27
+61% +$69.6K ﹤0.01% 2696
2017
Q3
$124K Sell
44
-6
-12% -$16.9K ﹤0.01% 2612
2017
Q2
$119K Sell
50
-738
-94% -$1.76M ﹤0.01% 2689
2017
Q1
$1.99M Buy
788
+299
+61% +$754K ﹤0.01% 1211
2016
Q4
$1.1M Sell
489
-307
-39% -$693K ﹤0.01% 1438
2016
Q3
$1.99M Sell
796
-854
-52% -$2.14M ﹤0.01% 1086
2016
Q2
$5.05M Buy
1,650
+1,133
+219% +$3.47M 0.01% 716
2016
Q1
$1.61M Buy
517
+283
+121% +$883K ﹤0.01% 1185
2015
Q4
$1.18M Sell
234
-2,076
-90% -$10.5M ﹤0.01% 1280
2015
Q3
$7.21M Buy
2,310
+2,303
+32,900% +$7.19M 0.01% 574
2015
Q2
$29K Sell
7
-7
-50% -$29K ﹤0.01% 2830
2015
Q1
$58K Sell
14
-30
-68% -$124K ﹤0.01% 2687
2014
Q4
$212K Sell
44
-10
-19% -$48.2K ﹤0.01% 2344
2014
Q3
$213K Sell
54
-43
-44% -$170K ﹤0.01% 2291
2014
Q2
$384K Buy
97
+33
+52% +$131K ﹤0.01% 2114
2014
Q1
$284K Sell
64
-336
-84% -$1.49M ﹤0.01% 2220
2013
Q4
$1.39M Sell
400
-347
-46% -$1.21M ﹤0.01% 1575
2013
Q3
$3.05M Sell
747
-14
-2% -$57.2K ﹤0.01% 1078
2013
Q2
$3.02M Buy
+761
New +$3.02M ﹤0.01% 1074